• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Merck KGaA

parachute chutes
Biotech

Protara gears up for next commercial steps—Chutes & Ladders

Protara gears up for next steps with commercial pro. Instil installs Big Pharma vet as CMO. Orca hauls in Carvykti commercial leader.
Darren Incorvaia , Zoey Becker Jun 6, 2025 8:30am
An arrow incrementally going up stairs before pointing straight up Blue background

Merck KGaA posts tumor data ahead of showdown with Daiichi, Ono

May 28, 2025 8:45am
photo of the exterior of EMD Serono

After setback, Merck KGaA shows data justifying lupus ph. 3 push

May 21, 2025 9:50am
Heidelberg Germany

German program matches lost NIH grants with pharma funders

Apr 7, 2025 10:50am
Three blocks displaying from left to right a person a handshake and another person

Merck KGaA pays $85M for global rights to Abbisko's tumor drug

Apr 1, 2025 7:40am
bumpy road rough bad path

Merck KGaA fails lupus trial arm, plans further development

Mar 6, 2025 7:25am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings